medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2018, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2018; 63 (2)

Acceptability of the influenza virus vaccination in cancer patients

Shveid GD, Tapia SR, O’Neill GP, Rodríguez AAN, Lecona GJD, Pérez CAM

Language: Spanish
References: 21
Page: 105-110
PDF size: 184.21 Kb.


ABSTRACT

Globally in 2016, nearly one hundred and five thousand deaths were reported because of the influenza virus. The elderly and those with comorbidities were the most affected population. Oncologic patients, specifically those with lung cancer and hematologic neoplasms have a greater risk of death related to the infection of the virus. Immunization against influenza virus is considered an important tool in those with chronic conditions including patients with immunosuppression where it can reduce the risk of illness caused by influenza virus infection by 50- to 60 %. Due to the above it is important that the physicians encourage this population to receive annual influenza vaccination. However, this strategy is only applied in 5.3% of the oncologic patients who indeed have the major need to be protected but at the same time a lower immune response to the vaccine.


REFERENCES

  1. Global Burden of Disease. Lancet. 2016. [Consulted 11 November 2017. Available in: http://www.thelancet.com/gbd/2016.

  2. Centers for Diseases Control and Prevention. Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States. Burden of Influenza. [Consulted 11 November 2018] Available in: https://www.cdc.gov/flu/about/disease/2015-16.htm

  3. CONAVE: Comisión Nacional para la vigilancia Epidemiológica. Actualización de la situación de influenza durante la Temporada 2015-2016. [Consultada 26 Marzo 2018].

  4. Centers for Diseases Control and Prevention. Cancer, the Flu, and You. [Consulted 18 November 2018] Available in: https://www.cdc.gov/cancer/flu/index.htm

  5. Boehmer LM, Waqar SN, Govindan R. Influenza vaccination in patients with cancer: an overview. Oncology (Williston Park). 2010; 24 (12): 1167-1170.

  6. Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K et al. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness-United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018; 67 (6): 180-185. doi: http://dx.doi.org/10.15585/mmwr.mm6706a2.

  7. Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 2005; 3 (4): 214-220.

  8. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer. 2000; 82 (7): 1261-1265.

  9. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis. 1993; 12: 778-782. Available in: https://www.gob.mx/cms/uploads/attachment/file/225143/AE_influenza_100216.pdf

  10. Center for Disease Control and Prevention Vaccine Effectiveness. How well does the flu vaccine work? [Consulted 16 November 2017] Available in: https://www.cdc.gov/flu/about/qa/vaccineeffect.htm

  11. Rubin L, Levin MJ, Jungman P, Davies EG, Avery R, Marcie T et al. IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. CID 2014: 58.

  12. Organización Mundial de la Salud. Temas de Salud. Cáncer. [Consultada 12 Diciembre 2017] Disponible en: http://www.who.int/topics/cancer/es/

  13. American Society of Clinical Oncology (ASCO) Cancer.Net: Términos relativos al cáncer: después del tratamiento. [Consultada 12 Noviembre 2017] Disponible en: https://www.cancer.net/es/desplazarse-por-atenci%C3%B3n-del-c%C3%A1ncer/recursos-de-diccionarios-m%C3%A9dicos/t%C3%A9rminos-relativos-al-c%C3%A1ncer-despu%C3%A9s-del-tratamiento

  14. Instituto Nacional del Cáncer. Diccionario de cáncer. [Consultada 14 Noviembre 2017]. Disponible en: https://www.cancer.gov/espanol/publicaciones/diccionario?cdrid=45867

  15. Robin C, Beckerich F, Cordonnier C. Immunization in cancer patients: where we stand. Pharmacol Res. 2015; 92: 23-30.

  16. Poeppl W, Lagler H, Raderer M, Sperr WR, Zielinski C, Herkner H et al. Influenza vaccination perception and coverage among patients with malignant disease. Vaccine. 2015; 33 (14): 1682-1687.

  17. Worasathit R, Wattana W, Okanurak K, Songthap A, Dhitavat J, Pitisuttithum P. Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults. BMC Geriatr. 2015; 15: 136.

  18. Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy. A systematic review. Vaccine. 2015; 33 (34): 4180-4190.

  19. Center for Disease Control and Prevention. Misconceptions about seasonal flu and flu vaccines. [Consulted 26 April 2018] Available in: https://www.cdc.gov/flu/about/qa/misconceptions.htm

  20. Mesch GS, Schwirian KP. Social and political determinants of vaccine hesitancy. Am J Infect Control. 2015; 43 (11): 1161-1165.

  21. Schmid P, Rauber D, Betsch C, Lidolt G, Denker M. Barriers of Influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005-2016. PLoS ONE. 2017; 12 (1): 1-46.




2020     |     www.medigraphic.com